D R Khasanova Selected Research

dimephosphon

1/2021

[The efficacy of the anti-acidemic agent dimephosphone at the first rehabilitation stage in patients in the acute period of carotid-related ischemic stroke].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D R Khasanova Research Topics

Disease

7	Ischemic Stroke 01/2022 - 01/2008
3	Stroke (Strokes) 01/2020 - 01/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2012 - 01/2009
1	COVID-19 01/2021
1	Paresis (Hemiparesis) 01/2017
1	Leukocytosis (Pleocytosis) 01/2016
1	Reperfusion Injury 01/2009
1	Embolic Stroke 01/2009

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 01/2009
1	RivaroxabanIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	dimephosphonIBA 01/2021
1	emoxypine succinateIBA 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2017
1	Antithrombin IIIIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Hemostatics (Antihemorrhagics)IBA 01/2016
1	Paroxetine (Paxil)FDA LinkGeneric 01/2012
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2009
1	Neuroprotective AgentsIBA 01/2009
1	Amantadine (Aman)FDA LinkGeneric 01/2009

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2008
1	Transcranial Magnetic Stimulation 01/2020
1	Neurological Rehabilitation 01/2017